Participants 103 149 5
acute bacterial maxillary sinusitis in adults.
Participants 229 323 5
outpatients with both clinical signs and symptoms and radiographic evidence of acute sinusitis
Participants 501 723 7
452 patients considered valid for clinical efficacy, faropenem daloxate treatment was found to be statistically equivalent to cefuroxime axetil (89.0% vs. 88.4%-95% CI=-5.2%; +6.4%) at the 7-16 days post-therapy assessment
